End-stage renal failure and national resources: the Brazilian experience.
Brazil is the fifth largest and the fifth most populous nation in the world. Its economy rivals Mexico as the strongest in Latin America and ranks among the 15 largest economies in the world. Despite these achievements, a substantial fraction of the Brazilian population still lives in poverty, and many still have limited access to medical assistance. There are currently about 380 patients on hemodialysis per million populations (pmp), approximately one third of the U.S. prevalence, suggesting that a large fraction of end-stage renal disease (ESRD) patients are not diagnosed and treated properly. In Brazil, access to renal replacement therapy (RRT), including renal transplantation, is universal, and the corresponding costs, including those of medications (immunosuppressors and treatment of ESRD complications), are covered by the Brazilian government. However, given the continuous growth of the ESRD population and of the costs incurred by RRT, the efficacy and reach of this system may be severely limited in years to come. In the current struggle against the ESRD epidemics, the Brazilian medical community and health authorities face a triple challenge: to limit the incidence of renal disease, slow or detain the progression of established chronic nephropathies, and ensure that access to quality RRT remains granted to all those who, despite all efforts, reach ESRD.
Zatz
Roberto
R
Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo, Av. Dr. Arnaldo 455, CEP 01246-903 São Paulo, SP, Brazil. rzatz@usp.br
Romão
João Egídio
JE
D001938:Brazil / Q000453:epidemiology; D002202:Capital Financing / Q000191:economics; D017048:Health Care Costs; D006295:Health Resources; D006801:Humans; D007676:Kidney Failure, Chronic / Q000191:economics / Q000453:epidemiology* / Q000628:therapy; D017582:Renal Replacement Therapy / Q000191:economics